arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CVS HEALTH Corp

CVS
$95.69 ▼ -0.47 (-0.49%) at close
Healthcare ·Retail-Drug Stores and Proprietary Stores ·USRetail-Drug Stores and Proprietary Stores
20 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Bullish
auto_awesome

Analytical Summary

CVS HEALTH Corp shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $121.2B
Dividend Yield 2.78%
Revenue Growth 7.8%
Op. Margin 1.2%
ROIC 5.0%
FCF / Share $6.16
Trailing P/E 68.4x
Price / Book 1.6x
FCF Yield 6.4%
Debt / Equity 0.00
info Valuation on last close. End-of-day price, Aug 7, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$402.07B
↑ +7.8%
Net Income Profit after all expenses
$1.77B
↓ -61.7%
Operating Margin Operating profit as % of sales
1.2%
↓ -49.3% 31th
FCF / Share Free cash flow per share
$6.16
↑ +22.6%
Long-Term Debt Long-term obligations
$73.43B
↑ +171.9%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
32
Returns
48
Financial Health
77
Cash Quality
94

Dividend History

Dividend / share · sourced from SEC filings
$2.66 Latest / share
+0.0% YoY
+8.4% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters